DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ ...
The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin.
ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...
Biolinq announced today that it received FDA de novo clearance for its lead product, the Biolinq Shine wearable biosensor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback